01—History
Long-Term Debt History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $46.75B
1 older move runs past ±50% (largest +308.2%); point at, tap or drag across the bars to read one.
02—Ledger
Long-Term Debt, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $46.75B | +35.7% | 10-K | |
| FY2024 | $34.46B | +2.3% | 10-K | |
| FY2023 | $33.68B | +17.2% | 10-K | |
| FY2022 | $28.75B | −6.3% | 10-K | |
| FY2021 | $30.69B | +21.0% | 10-K | |
| FY2020 | $25.36B | +11.5% | 10-K | |
| FY2019 | $22.74B | +14.8% | 10-K | |
| FY2018 | $19.81B | −7.2% | 10-K | |
| FY2017 | $21.35B | −12.0% | 10-K | |
| FY2016 | $24.27B | +1.9% | 10-K | |
| FY2015 | $23.83B | +27.4% | 10-K | |
| FY2014 | $18.70B | −9.0% | 10-K | |
| FY2013 | $20.54B | +26.4% | 10-K | |
| FY2012 | $16.25B | +4.7% | 10-K | |
| FY2011 | $15.53B | +0.3% | 10-K | |
| FY2010 | $15.48B | −3.8% | 10-K | |
| FY2009 | $16.09B | +308.2% | 10-K | |
| FY2008 | $3.94B | — | 10-K |
03—Questions
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is Merck's current long-term debt?
Merck (MRK) annual long-term debt for 2025 was $46.75B, a 35.66% increase from 2024. Merck long-term debt for the quarter ending September 30, 2026 was $49.69B.
What was Merck's long-term debt in 2024?
Merck annual long-term debt for 2024 was $34.46B, a 2.31% increase from 2023.
What was Merck's long-term debt in 2023?
Merck annual long-term debt for 2023 was $33.68B, a 17.18% increase from 2022.
What is Merck's 5-year long-term debt CAGR?
Merck long-term debt grew at a compound annual growth rate (CAGR) of 13.01% from FY2020 to FY2025, going from $25.36B to $46.75B over 5 years.
- Company
- Merck
- Ticker
- MRK
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations